Amyloid-beta binding molecule: potential role in the pathogenesis and treatment of Alzheimer disease.
Holtzman
David M
DM
Department of Neurology, Molecular Biology of Pharmacology, Washington University Alzheimer's Research Center, St. Louis, Missouri, USA. holtzman@neuro.wustl.edu
D000544:Alzheimer Disease / Q000503:physiopathology* / Q000628:therapy*; D016564:Amyloid beta-Protein Precursor / Q000276:immunology / Q000494:pharmacology*; D001053:Apolipoproteins / Q000494:pharmacology*; D006801:Humans; D007114:Immunization
D016564:Amyloid beta-Protein Precursor; D001053:Apolipoproteins